Evaluation of Olaparib Efficacy Following CDK4/6 Inhibitor Therapy in BRCA-Mutated, Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Turkish Oncology Group (TOG) Study.

---

Gökdere Z. S., Şahin T. K., Bilgetekin İ., Baytemur N. K., Seyyar M., Yazıcı M., ...Daha Fazla

Targeted oncology, 2026 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası:
• Basım Tarihi: 2026
• Doi Numarası: 10.1007/s11523-026-01261-w
• Dergi Adı: Targeted oncology
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CINAHL, EMBASE, MEDLINE, Biomedical Reference Collection: Corporate Edition (EBSCO), Health Research Premium Collection (ProQuest), Pharma Collection (ProQuest)
• Bursa Uludağ Üniversitesi Adresli: Evet